Johnson & Johnson (JNJ)

Over the past ten years, Johnson & Johnson (NYSE: JNJ) has delivered an impressive $157 Bil back to its investors through cash distributions via dividends and buybacks. This commitment to shareholder ...

Investors who find themselves awake at night thinking about their portfolios, fear not.

Some stocks simply pay a regular dividend. The smarter ones also raise their dividend payout every year, putting more cash in their shareholders' pockets.

Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristoc...

Johnson & Johnson (JNJ) closed at $179.71 in the latest trading session, marking a +1.11% move from the prior day.

Johnson & Johnson (JNJ 0.57%) is a longtime healthcare leader with numerous positive qualities. These include its 62 consecutive years of dividend increases, which surpass the 50 required to be recogn...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.